A report describing “predominantly parabasal cells” means that the sample taken from your cervix or vaginal wall is made up mostly of small, immature cells from the deepest layer of the vaginal lining. This is almost always a sign of low estrogen rather than anything cancerous. It tells your clinician that the vaginal tissue is thin and under-stimulated hormonally, a state commonly called vaginal atrophy. The finding is extremely common after menopause, but it can also show up during breastfeeding, after certain cancer treatments, or in other low-estrogen states.
What Parabasal Cells Are and Why They Show Up
The lining of the vagina and cervix is made of layers of flat (squamous) cells that mature as they move from the base toward the surface. The youngest, smallest cells sit at the bottom and are called parabasal cells. Above them are intermediate cells, and the most mature cells at the surface are called superficial cells. When estrogen levels are healthy, it drives those bottom-layer cells to multiply and mature, producing a thick lining dominated by intermediate and superficial cells. A Pap smear or vaginal cytology sample taken from a well-estrogenized person will mostly contain those larger, mature cells.
When estrogen drops, that maturation process stalls. The lining thins dramatically, and the cells that shed into a sample are predominantly the small, round parabasal type. A predominance of parabasal cells with few or no superficial cells is the cytologic hallmark of low circulating estrogen.1PubMed Central. Prevalence and Correlates of Vaginal Estrogenization in Postmenopausal Women in the United States In animal models, removing estrogen signaling from the vaginal epithelium reduces the tissue’s thickness by more than half and eliminates the protective outer cornified layer entirely.2Nature Publishing Group / Scientific Reports. Estrogen Action in the Epithelial Cells of the Mouse Vagina Regulates Neutrophil Infiltration and Vaginal Tissue Integrity
The Most Common Reason You Would See This on a Report
Menopause is by far the most frequent cause. Before menopause, the predominant cells on a Pap smear are intermediate and superficial, and parabasal cells are scarce. After menopause, as ovarian estrogen production drops, parabasal cells increase and superficial cells diminish or disappear.3Australian Family Physician. Genitourinary syndrome of menopause This shift is so reliable that clinicians historically used the ratio of parabasal, intermediate, and superficial cells as a rough gauge of a woman’s estrogen status.4PubMed Central. Nonneoplastic Cervical Cytology
If you are postmenopausal and your report says “predominantly parabasal cells,” “atrophic pattern,” or “atrophic vaginitis,” these all describe the same thing: your vaginal lining reflects the lower estrogen levels that come naturally with menopause. It is not a disease diagnosis on its own. It is a description of what the cells look like under the microscope.
Other Situations That Produce the Same Finding
Menopause gets most of the attention, but several other situations can drive estrogen low enough for parabasal cells to dominate a sample.
Postpartum and Breastfeeding
After delivery, the placenta is gone and estrogen plummets. The navicular cells typical of pregnancy are rapidly replaced by parabasal cells.5CytoJournal. Nonneoplastic Cervical Cytology If you are breastfeeding, the hormonal suppression of ovarian cycling keeps estrogen low, and the atrophic pattern can persist for months. Research on postpartum vaginal smears found that atrophic patterns predominated in lactating women for weeks after delivery, while only about a third of non-breastfeeding mothers showed the same pattern during that window.6PubMed. Hormonal patterns in vaginal smears from puerperal women Once breastfeeding stops and ovarian cycling resumes, the cell pattern gradually returns to a mature one.
Medications That Lower Estrogen
Certain drugs prescribed for breast cancer treatment are designed to suppress estrogen, and the vaginal lining responds predictably. Aromatase inhibitors, which block the enzyme that converts androgens into estrogen, cause reduced vaginal cell proliferation and signs of atrophy.7PubMed Central. Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors GnRH agonists used for endometriosis or fibroids, and some forms of hormonal contraception that suppress ovulation strongly, can also tip the balance. Chemotherapy and pelvic radiation can damage the ovaries and produce low estrogen states as well. If you are on any of these treatments and your Pap report mentions parabasal cells, it is the expected side effect of the treatment rather than a new problem.
Young Women and Adolescents
Before puberty, when estrogen production has not yet ramped up, the vaginal epithelium is thin and parabasal-dominant. This is normal for the age. In rare cases, young women of reproductive age can have a parabasal-dominant smear if they have a condition that affects ovarian function, such as premature ovarian insufficiency or hypothalamic amenorrhea from extreme weight loss or intense exercise.
Symptoms That Go Along With It
A predominantly parabasal cell pattern is a lab finding, but the thinned-out vaginal lining it reflects usually comes with real physical symptoms. The combination of vaginal thinning, dryness, and urinary complaints is now called genitourinary syndrome of menopause. Changes in vaginal pH correlate with the shift toward parabasal cells, and both track closely with symptoms like vaginal dryness and pain during intercourse.8PubMed Central / Wolters Kluwer. Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women
The thin lining is more fragile, more prone to micro-tears, and less able to maintain the acidic environment that keeps infections at bay. Some people experience vaginal irritation, burning, or discharge even without an infection. Others notice increased urinary urgency or recurrent urinary tract infections. Not everyone with a parabasal-dominant smear has noticeable symptoms, though. Some people are essentially asymptomatic and only learn about the finding from a routine Pap result.
When Parabasal Cells Signal Something Else Entirely
Low estrogen accounts for the vast majority of “predominantly parabasal” reports, but there are less common situations where a flood of parabasal cells points to inflammation rather than hormone deficiency. Desquamative inflammatory vaginitis is a condition defined in part by an increase in parabasal cells alongside a spike in inflammatory white blood cells on wet mount microscopy.9PubMed. Desquamative inflammatory vaginitis This condition causes heavy purulent discharge and irritation, and it can occur in premenopausal women with otherwise normal estrogen levels. The treatment is different from simple estrogen replacement, typically involving intravaginal corticosteroids or clindamycin, so distinguishing it from straightforward atrophy matters.
Your clinician can usually tell the difference based on your age, symptoms, and what else the sample shows. A postmenopausal person with no discharge and a clean background on the slide is dealing with atrophy. A premenopausal person with copious discharge and lots of white blood cells alongside those parabasal cells warrants a closer look for an inflammatory or infectious cause.
The Diagnostic Problem Parabasal Cells Create
Here is where the finding gets genuinely tricky, and where it matters most that your clinician understands what they are looking at. Parabasal cells can mimic precancerous changes on a Pap smear. These small cells naturally have a high ratio of nucleus to overall cell size, and even a slight increase in that ratio or in how dark the nucleus stains can make a benign parabasal cell look suspiciously like a cell from a high-grade squamous lesion. The nuclear membranes in benign parabasal cells are smooth and uniform, which helps distinguish them, but the overlap is enough to cause false alarms. In some cases, even tissue biopsies can give a misleading result, and special staining techniques may be needed to sort things out.10CytoJournal. The gray zone squamous lesions: ASC-US / ASC-H
This means that if you are postmenopausal and your Pap smear comes back with an ambiguous reading like “atypical squamous cells” alongside an atrophic background, the abnormality may be nothing more than the atrophy itself confusing the picture. This is a well-recognized issue in cervical screening, and it has a practical solution.
How Estrogen Treatment Clears Up the Picture
When a Pap smear is hard to interpret because of atrophy, clinicians often prescribe a short course of vaginal estrogen cream before repeating the test. The idea is straightforward: if you restore estrogen to the vaginal tissue, the cells mature, the lining thickens, and a repeat sample gives the pathologist bigger, more recognizable cells to evaluate. In a randomized trial, a course of vaginal estrogen used for five nights before repeat screening dramatically reduced the odds of getting another atrophic smear compared to no treatment.11PubMed. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears
Topical estrogen cream has been shown to cause complete disappearance of parabasal cells from the maturation index, with a measurable improvement in the overall atrophic index compared to placebo.12Obstetrics & Gynecology. Effect of vulvovaginal estrogen on sensorimotor response of the lower genital tract: a randomized controlled trial This does not just help with screening accuracy. For people with symptomatic vaginal atrophy, the estrogen also relieves dryness and discomfort.
If your colposcopy (the close-up examination done after an abnormal Pap) is unsatisfactory because the transformation zone is hard to see in atrophic tissue, your clinician may prescribe vaginal estrogen cream twice weekly for about six weeks before bringing you back for a repeat examination.13PubMed. Abnormal cervicovaginal cytology, unsatisfactory colposcopy and the use of vaginal estrogen cream: an observational study of clinical outcomes for women in low estrogen states The goal is to plump up the tissue enough for the clinician to get a clear view and a reliable biopsy if one is needed.
What Your Report Does and Does Not Tell You
Reading a cytology report can be anxiety-inducing, especially when you see unfamiliar terms. A few points are worth keeping straight.
“Predominantly parabasal cells” is a descriptive finding about the types of cells present. It is not a diagnosis of disease. It does not mean dysplasia (precancerous changes), and it does not mean cancer. It tells your clinician that your estrogen level is low enough to affect the vaginal lining, which is useful clinical information but not, on its own, alarming.
If the report also says “negative for intraepithelial lesion or malignancy” (often abbreviated NILM), that is the all-clear. The parabasal cells are noted as context, and no abnormal cells were identified. If the report instead flags something ambiguous, like ASC-US (atypical squamous cells of undetermined significance), the parabasal-dominant background is important context. It means the ambiguity may be caused by the atrophy itself, and a short course of vaginal estrogen followed by a repeat Pap may resolve the question without any invasive procedure.
If you are on an estrogen-suppressing medication for cancer treatment and wondering whether vaginal estrogen is safe for you, that is a conversation for your oncologist. The systemic absorption from vaginal estrogen preparations is generally very low, but the decision involves weighing the specific type and stage of cancer against the severity of your symptoms.
Why the Maturation Index Still Gets Used
You may see the term “maturation index” or “vaginal maturation index” on your report or in educational material about your results. This is a simple count: a pathologist classifies 100 or 200 cells from the sample as parabasal, intermediate, or superficial, and expresses the result as a ratio. A fully estrogenized sample might read something like 0/40/60 (no parabasal, 40 percent intermediate, 60 percent superficial), while a severely atrophic sample might read 80/20/0 (80 percent parabasal, 20 percent intermediate, no superficial cells).
The maturation index is not a precise hormone assay. It gives a rough visual snapshot of how the tissue is responding to whatever estrogen is circulating. It is useful for tracking whether treatment is working: if you start vaginal estrogen and a follow-up sample shows a shift from parabasal-dominant to intermediate-dominant, the tissue is responding. Researchers also use it in clinical trials as an objective measure of vaginal atrophy. But it has limits. Two women with the same blood estrogen level can have different maturation indices, because local tissue factors, inflammation, and even the technique used to collect the sample all influence the result.
The Vaginal pH Connection
One of the more practical things to understand about a parabasal-dominant vaginal environment is what it does to vaginal pH. A healthy, well-estrogenized vagina maintains an acidic pH, usually between 3.8 and 4.5, thanks to the glycogen stored in mature superficial cells. Lactobacillus bacteria feed on that glycogen and produce lactic acid, which keeps the environment hostile to most pathogens. When the lining thins and parabasal cells dominate, there is far less glycogen, fewer lactobacilli, and the pH rises above 5 or even above 6.
The shift in pH is strongly correlated with the shift in cell types on cytology and with symptoms of dryness and pain.8PubMed Central / Wolters Kluwer. Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women The elevated pH also makes the vagina more vulnerable to infections like bacterial vaginosis and urinary tract infections. Some clinicians use a simple pH test strip at the office visit as a quick screen for atrophic changes, since it is cheap, immediate, and correlates well with what the cytology will eventually show.
When Estrogen Is Not the Answer
Not everyone with a parabasal-dominant pattern can or wants to use estrogen. People with estrogen-receptor-positive breast cancer are often advised to avoid even local vaginal estrogen, depending on their oncologist’s judgment. Others may simply prefer non-hormonal options. In those cases, vaginal moisturizers used regularly (not just during intercourse) can help maintain tissue hydration and comfort, though they will not change the underlying cytology. Lubricants during intercourse reduce friction and irritation. Ospemifene, an oral medication that acts like estrogen on vaginal tissue but not on breast tissue, is an option for some people, though it comes with its own set of considerations and side effects.
For people whose atrophic smear is creating diagnostic confusion but who cannot use estrogen, clinicians rely more heavily on HPV testing. A negative HPV test in the context of an ambiguous atrophic Pap is very reassuring, because cervical cancer almost always involves HPV infection. If the HPV test is negative, the odds that those ambiguous-looking parabasal cells represent a true precancerous lesion are extremely low, regardless of how worrying they look under the microscope.